4.4 Article

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Malaria control in Bhutan: case study of a country embarking on elimination

Thinley Yangzom et al.

MALARIA JOURNAL (2012)

Article Microbiology

In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda

Samuel L. Nsobya et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Parasitology

Monitoring antimalarial resistance: launching a cooperative effort

Carol Hopkins Sibley et al.

TRENDS IN PARASITOLOGY (2010)

Article Medicine, General & Internal

Artemisinin Resistance in Plasmodium falciparum Malaria.

Arjen M. Dondorp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Public, Environmental & Occupational Health

In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda

H Tinto et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)

Article Public, Environmental & Occupational Health

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

H Barennes et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)

Review Infectious Diseases

Epidemiology of drug-resistant malaria

C Wongsrichanalai et al.

LANCET INFECTIOUS DISEASES (2002)

Article Public, Environmental & Occupational Health

Using evidence to change antimalarial drug policy in Kenya

R Shretta et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)

Article Public, Environmental & Occupational Health

In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma,Tanzania

E Gorissen et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)